BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 20418914)

  • 1. The Eyes Absent phosphatase-transactivator proteins promote proliferation, transformation, migration, and invasion of tumor cells.
    Pandey RN; Rani R; Yeo EJ; Spencer M; Hu S; Lang RA; Hegde RS
    Oncogene; 2010 Jun; 29(25):3715-22. PubMed ID: 20418914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The EYA tyrosine phosphatase activity is pro-angiogenic and is inhibited by benzbromarone.
    Tadjuidje E; Wang TS; Pandey RN; Sumanas S; Lang RA; Hegde RS
    PLoS One; 2012; 7(4):e34806. PubMed ID: 22545090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The multi-functional eyes absent proteins.
    Hegde RS; Roychoudhury K; Pandey RN
    Crit Rev Biochem Mol Biol; 2020 Aug; 55(4):372-385. PubMed ID: 32727223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Eya phosphatase: Its unique role in cancer.
    Zhou H; Zhang L; Vartuli RL; Ford HL; Zhao R
    Int J Biochem Cell Biol; 2018 Mar; 96():165-170. PubMed ID: 28887153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WDR1 is a novel EYA3 substrate and its dephosphorylation induces modifications of the cellular actin cytoskeleton.
    Mentel M; Ionescu AE; Puscalau-Girtu I; Helm MS; Badea RA; Rizzoli SO; Szedlacsek SE
    Sci Rep; 2018 Feb; 8(1):2910. PubMed ID: 29440662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. All eyes on Eya: A unique transcriptional co-activator and phosphatase in cancer.
    Hughes CJ; Alderman C; Wolin AR; Fields KM; Zhao R; Ford HL
    Biochim Biophys Acta Rev Cancer; 2024 May; 1879(3):189098. PubMed ID: 38555001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor {beta} (TGF-{beta})-Smad target gene protein tyrosine phosphatase receptor type kappa is required for TGF-{beta} function.
    Wang SE; Wu FY; Shin I; Qu S; Arteaga CL
    Mol Cell Biol; 2005 Jun; 25(11):4703-15. PubMed ID: 15899872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Eyes Absent proteins in development and disease.
    Tadjuidje E; Hegde RS
    Cell Mol Life Sci; 2013 Jun; 70(11):1897-913. PubMed ID: 22971774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eya3 promotes breast tumor-associated immune suppression via threonine phosphatase-mediated PD-L1 upregulation.
    Vartuli RL; Zhou H; Zhang L; Powers RK; Klarquist J; Rudra P; Vincent MY; Ghosh D; Costello JC; Kedl RM; Slansky JE; Zhao R; Ford HL
    J Clin Invest; 2018 Jun; 128(6):2535-2550. PubMed ID: 29757193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Eyes Absent Proteins in Developmental and Pathological Angiogenesis.
    Wang Y; Tadjuidje E; Pandey RN; Stefater JA; Smith LE; Lang RA; Hegde RS
    Am J Pathol; 2016 Mar; 186(3):568-78. PubMed ID: 26765957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility.
    Fiordalisi JJ; Keller PJ; Cox AD
    Cancer Res; 2006 Mar; 66(6):3153-61. PubMed ID: 16540666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EYA4 promotes breast cancer progression and metastasis through its role in replication stress avoidance.
    de la Peña Avalos B; Tropée R; Duijf PHG; Dray E
    Mol Cancer; 2023 Sep; 22(1):158. PubMed ID: 37777742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of PRL-3 regulates proliferation and invasion of breast cancer cells in vitro.
    Radke I; Götte M; Smollich M; Scharle N; Kiesel L; Wülfing P
    Arch Gynecol Obstet; 2017 Dec; 296(6):1153-1160. PubMed ID: 28980126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MLK3 is critical for breast cancer cell migration and promotes a malignant phenotype in mammary epithelial cells.
    Chen J; Miller EM; Gallo KA
    Oncogene; 2010 Aug; 29(31):4399-411. PubMed ID: 20514022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the threonine-phosphatase of mouse eyes absent 3.
    Sano T; Nagata S
    FEBS Lett; 2011 Sep; 585(17):2714-9. PubMed ID: 21821028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SIX1-EYA transcriptional complex as a therapeutic target in cancer.
    Blevins MA; Towers CG; Patrick AN; Zhao R; Ford HL
    Expert Opin Ther Targets; 2015 Feb; 19(2):213-25. PubMed ID: 25555392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heregulin regulates the actin cytoskeleton and promotes invasive properties in breast cancer cell lines.
    Hijazi MM; Thompson EW; Tang C; Coopman P; Torri JA; Yang D; Mueller SC; Lupu R
    Int J Oncol; 2000 Oct; 17(4):629-41. PubMed ID: 10995872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rac1 and Rac3 isoform activation is involved in the invasive and metastatic phenotype of human breast cancer cells.
    Baugher PJ; Krishnamoorthy L; Price JE; Dharmawardhane SF
    Breast Cancer Res; 2005; 7(6):R965-74. PubMed ID: 16280046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eya3 partners with PP2A to induce c-Myc stabilization and tumor progression.
    Zhang L; Zhou H; Li X; Vartuli RL; Rowse M; Xing Y; Rudra P; Ghosh D; Zhao R; Ford HL
    Nat Commun; 2018 Mar; 9(1):1047. PubMed ID: 29535359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphatase of regenerating liver-1 promotes cell migration and invasion and regulates filamentous actin dynamics.
    Nakashima M; Lazo JS
    J Pharmacol Exp Ther; 2010 Aug; 334(2):627-33. PubMed ID: 20484558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.